Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
PERI
AprilBio
★★

AprilBio 2026 Q1: Evommune Milestone Revenue and 95 Billion KRW Cash Holdings

  05/15/2026, 03:03 PM
EXCH
AprilBio
★

Early termination of SAFA fusion protein contract with Yuhan, strategic shift

  05/04/2026, 04:21 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.